Currently out of the existing stock ratings of Christopher Parkinson, 238 are a BUY (53.85%), 196 are a HOLD (44.34%), 8 are a SELL (1.81%).

Christopher Parkinson

Work Performance Price Targets & Ratings Chart

Analyst Christopher Parkinson, currently employed at MIZUHO, carries an average stock price target met ratio of 64.93% that have a potential upside of 38.28% achieved within 430 days. Previously, Christopher Parkinson worked at CREDIT SUISSE, WOLFE.

Christopher Parkinson’s has documented 833 price targets and ratings displayed on 35 stocks. The coverage is on Basic Materials, Consumer Cyclical, Technology, Industrials sectors.

Most recent stock forecast was given on IFF, International Flavors & Fragrances at 08-Sep-2025.

Wall Street Analyst Christopher Parkinson

Analyst best performing recommendations are on ENTG (ENTEGRIS).
The best stock recommendation documented was for CTVA (CORTEVA) at 11/6/2020. The price target of $34 was fulfilled within 4 days with a profit of $2.3 (7.26%) receiving and performance score of 18.14.

Average potential price target upside

ALB Albemarle Corp BERY Berry Global Group CCK Crown Holdings CF CF Industries Holdings CTVA Corteva DD Dupont De Nemours ECL Ecolab FMC FMC GRA W. R. Grace LYB LyondellBasell Industries NV NTR Nutrien Ltd PPG PPG Industries SHW Sherwin-Williams Co ASH Ashland Global Holdings AXTA Axalta Coating Systems Ltd BLL Ball DSEY Diversey Holdings Ltd GPK Graphic Packaging Holding Company IFF International Flavors & Fragrances LIN Linde plc Ordinary Shares LTHM Livent Corp PTVE Pactiv Evergreen SEE Sealed Air APD Air Products and Chemicals CMP Compass Minerals International MOS The Mosaic Company BALL Ball DOW Dow ESI Element Solutions ENTG Entegris BE Bloom Energy Corp DDD 3D Systems LTH Life Time Group Holdings VAL Valaris Ltd BL Blackline

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 28-Feb-2023

$140

$29.09 (26.23%)

$195

26 days ago
(25-Aug-2026)

7/8 (87.5%)

$6.82 (5.12%)

13

Buy Since 14-May-2026

$190

$79.09 (71.31%)

$200

1 months 10 days ago
(10-Aug-2026)

9/14 (64.29%)

$58.79 (44.81%)

322

Buy Since 10-May-2022

$157

$46.09 (41.56%)

$257

1 months 10 days ago
(10-Aug-2026)

34/46 (73.91%)

$25.79 (19.66%)

466

Buy Since 22-Apr-2026

$225

$114.09 (102.87%)

$245

1 months 13 days ago
(07-Aug-2026)

6/12 (50%)

$93.89 (71.61%)

140

Hold Since 04-Jan-2024

$185

$74.09 (66.80%)

$205

2 months 19 days ago
(01-Jul-2026)

44/45 (97.78%)

$48.92 (35.95%)

181

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Christopher Parkinson?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?